Characteristics | MRSA (n = 59) | MSSA (n = 95) | Gram negative (n = 182) |
---|---|---|---|
Demographics | |||
Age (median [IQR]; years) | 74 (64–81) | 67* (47–78) | 65† (53–76) |
Male | 55.9% | 52.6% | 63.2% |
Insurance | |||
Medicare | 67.8% | 49.5%* | 50.0%† |
Medicaid | 3.4% | 8.4% | 6.0% |
Managed care | 15.3% | 17.9% | 17.0% |
Comorbidities | |||
Immunosuppressed | 22.0% | 8.4%* | 12.1%† |
Cancer | 15.3% | 9.5% | 16.5% |
Diabetes mellitus | 39.0% | 28.4% | 25.8%† |
Chronic renal failure | 17.0% | 9.5% | 13.7% |
Congestive heart failure | 45.8% | 22.1%* | 19.8%† |
Median number of comorbidities (IQR) | 3 (1–5) | 2* (0–4) | 2 (1–3) |
Acute clinical presentation on admission | |||
Albumin <2.4 g/dl | 3.4% | 4.2% | 4.4% |
Arterial pH <7.3 | 5.1% | 13.7% | 8.2% |
Creatinine >1.5 mg/dl | 8.5% | 15.8% | 6.6% |
WBC <4.3 or >19.8 × 103/mm3 | 6.8% | 12.6% | 6.6% |
Bands >32% | 1.7% | 2.1% | 1.1% |
BUN >55 mg/dl | 10.2% | 5.3% | 4.4% |
BUN 40–55 mg/dl | 5.1% | 2.1% | 2.2% |
Temperature <35.6°C | 11.9% | 27.4%* | 14.8% |
Respiration >39 breaths/min | 5.1% | 4.2% | 0.6%† |
GCSc <6 | 27.1% | 16.8% | 20.3% |
Pleural effusion | 28.8% | 20.0% | 17.0%† |
Bacteremia | 10.2% | 14.7% | 7.1% |
ASGd ≥ 3 | 72.6% | 72.9% | 66.5% |
Care unit | |||
Trauma unit | 2.4% | 13.9%* | 15.1%† |
Major surgery | 11.9% | 17.9% | 26.9% |